MSD’s Post

⭐ Join us on Monday 6th November for the Pistoia Alliance-Industry collaborative initiative webinar. ▶️ The recently released white paper by the Health Systems task force of the Sustainable Market Initiative highlights the global clinical trial footprint, estimating it to be responsible for up to 100 million tons of greenhouse gas emissions annually. This has led to increased awareness of the environmental impact of clinical trials and the need for the pharmaceutical industry to measure their carbon footprint at a corporate level. The Pistoia Alliance initiative aims to standardize the evaluation of carbon footprint by building a model that involves members from different companies. The webinar will provide more details on the rationale and objectives of this project. Additionally, speakers will discuss sustainability in clinical research and the impact of travel on carbon emissions. 💡 Don't miss out on this opportunity to learn more about the efforts being made to reduce the environmental impact of clinical trials. #clinicaltrialsustainability #carbonfootprintmeasurement

🌍 💊 Exploring Sustainable Innovation: Nordic Pharma's 2023 CSR Report Nordic Pharma steps up in the pharmaceutical world, not just through advanced healthcare solutions but also by embedding sustainability into their core. The 2023 CSR Report unveils their journey towards a healthier planet and community. 🌟 Highlights: Commitment to carbon footprint reduction. Innovation in sustainable healthcare solutions. Strong focus on community engagement. With their vision, Nordic Pharma demonstrates how healthcare and environmental stewardship can progress together. 👉 Full Report: https://lnkd.in/enZWhEtf #SustainableHealthcare #CSRInnovation #EcoFriendlyHealthcare

Embracing #sustainability in our marketing strategies goes beyond eco-consciousness; it's about establishing a benchmark for compassionate and responsible engagement! By embedding sustainable practices into our operations, we demonstrate alignment with our Rare disease patients’ values: hope, health, and a commitment to preserving our planet for coming generations. Let’s open a dialogue: What innovative ideas can we implement in pharmaceutical marketing for rare diseases that advance the sustainability agenda? How can we ensure that our initiatives are not only effective but also ethically sound and environmentally sustainable? #RareDisease #Sustainability #PharmaMarketing #Innovation

8 Pharmaceutical companies, getting together, putting their best experts in the same room to develop a sector-wide, adapted standard for LCA. Every week, managing this project for Quantis has showed me the power of collective initiatives and how companies are eager to make a difference. More information on the project in the link below. #healthcare #LCA

🌱 Educating the Next Generation on Pharmaceutical Pollution 🌏 In a world where our healthcare system is constantly evolving and advancing, our future leaders must understand the environmental impact of our actions. Pharmaceuticals have undoubtedly improved our lives, but they also pose a significant threat to our ecosystems when disposed of improperly. Here are a few key takeaways from our workshop: 1) Definition of pharmaceutical waste: Expired, contaminated, or unused medications, drugs, vaccines, and medical products from healthcare, households, and manufacturing. 2) Impact towards humans: a) Toxicity to health: Individuals who encounter contaminated resources may have an adverse effect on their health. Long-term exposure to lower concentrations of complex pharmaceutical mixtures may result in acute and chronic damage, tissue accumulation, reproductive damage, and inhibition of cell proliferation. b)Accumulative Effects: Over time, cumulative exposure to pharmaceutical waste can lead to health complications c)Accidental Consumption: Expired or discarded medications can be inadvertently consumed, leading to incorrect dosages or unintended side effects. 3) The solution for this problem: ECO-SMART DISPOSAL a) Proper Disposal: Encourage everyone to dispose of unused or expired medications at designated collection sites or through drug take-back programs to prevent them from entering our waterways. b) Responsible Purchasing: When buying over-the-counter medications, choose products with minimal packaging, reducing unnecessary waste. Opt for eco-friendly packaging where possible. c)Support Eco-friendly Brands: Encourage and support pharmaceutical companies that prioritize sustainability and eco-friendly manufacturing processes. d)Educate Yourself: Stay informed about the environmental impact of pharmaceuticals and share this knowledge with friends and family. Knowledge is a powerful tool for change. e) Reduce Prescription Waste: Only take the prescribed amount of medication, and consult with healthcare professionals to reduce over-prescribing and minimize the need for disposal. Thank you ChM. DR. MUGGUNDHA RAOOV for conducting the program for the school students to have a better understanding of pharmaceutical pollution. Last but not least, thank you to Prof Sharifah, Ts. ChM. Dr. Kumuthini Chandrasekaram & and Kavirajaa Pandian Sambasevam for giving a wonderful presentation to the students. By taking these steps, we can collectively make a significant impact on reducing pharmaceutical pollution and safeguarding our environment for future generations. Let's all be part of the solution! 🌏💪 #PharmaceuticalPollution #Sustainability #EnvironmentalResponsibility #ActionForChange

🌎 Yesterday marked Earth Overshoot Day, a significant reminder of the urgent need for sustainable practices in every industry, including pharmaceuticals. As a pharmacist & RA specialist, I see firsthand the transformative impact that integrating sustainability with consumer health initiatives can have on our industry/world. ♻️ By optimizing energy efficiency, utilizing renewable resources, and transitioning to eco-friendly packaging, we not only meet regulatory standards but also elevate the consumer experience. Our commitment to sustainability drives innovation, ensuring that we deliver safe, effective, and environmentally responsible health solutions. Engaging with suppliers and partners who share our vision amplifies our efforts across the pharmaceutical value chain. Encouraging them to set and achieve ambitious climate targets is essential for reducing carbon emissions and enhancing overall product integrity. 💡 As we continue to advance in clinical research and product development, our focus remains on maintaining the highest standards of care while prioritizing sustainable practices. The intersection of regulatory compliance and environmental stewardship is where true PROGRESS happens, paving the way for a healthier future. 🚩Let's embrace this opportunity to lead by example in the pharma world, inspiring change and fostering a culture of sustainability and innovation. #SustainablePharma #ConsumerHealth #OTCProducts #ClinicalResearch #RegulatoryAffairs #PharmaInnovation #EnvironmentalStewardship #EarthOvershootDay #EcoFriendlyHealthcare #Sustainability

Save the date: At this week's Pharmapack Europe trade show, SCHOTT Pharma is co-organizing the #sustainability conference on Jan 25:   We're taking the lead in driving change towards a sustainable pharma industry by bringing together a lineup of speakers including academics, consultants, and industry experts to shed light on the vital question: How can we decarbonize drug containment and delivery products?   As for ourselves, our Head of Sustainability Arne Kloke together with Dr. Claudia Heinl from SCHOTT will announce an exciting milestone on how we plan to reduce emissions along the #supplychain: They will present our advancements along the decarbonization journey for primary packaging and our goal of becoming climate neutral by 2030.   The presentations from all experts will include: ➡️ Inspiration from success stories along sustainable healthcare initiatives ➡️ New insights into device take-back programs ➡️ Opportunities for low emission materials ➡️ Tailwind from regulations   I'm looking forward to building on this and joining our efforts for a sustainable future.   #BecauseHumanHealthMatters

"The world has finally woken up to the reality that the climate crisis is also a health crisis." Healthcare leaders from The Sustainable Markets Initiative Health Systems Task Force are taking significant steps to advance the decarbonization of the healthcare sector -- and Quantis is setting the environmental standards. In this collaborative initiative, which includes the Pharmaceutical Environment Group (PEG) and NHS England, Quantis is developing a sector-wide standard for life cycle assessment to enable robust measurement and reporting on the impacts of medicines and other healthcare products. Read more >> https://lnkd.in/e9XB4t_R #healthcare #decarbonization #renewableenergy

I highly recommend you stop by the G&L booth and discuss with Nathalie. You will learn all about our regulatory and quality capabilities!!